2RiziR DG, Healy S, Margulis A, et al. A new clinical classification for hospital proguosis of unstable angina Pectoris, Am J Cardiol, 1995,75(15) :993 -997.
3Fareed P, Waleugal, Kaman A. A modified stasis thromtosis model to study the antithromobic actions of heparin and fractions. Semin Thrombi Herost,1995,11 : 155.
二级参考文献4
1Fareed J, Hoppensteadt DA. Pharmacology of low molecular weight heparins. Semin Thromb Hemost, 1996, 22(Suppl 2): 13-18.
2Fragmin during instability in coronary artery disease (FRISC) study group. Low molecular weight heparin during instability in coronary artery disease. Lancet, 1996, 347:561-568.
3Fox KAA. Low molecular weight heparin (enoxaparin) in the management of unstable angina: the ESSENCE study. Heart, 1999, 82 (Suppl I):112-114.
